SciVision Biotech Inc. (1786.TW)
TWD 90.3
(-1.85%)
TWD 90.3
(-1.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 272.01 Million | 178.2 Million | 98.5 Million | 126.47 Million | 204.4 Million | 111.69 Million |
| Net Income | 209.99 Million | 173.55 Million | 116.05 Million | 152.48 Million | 134.27 Million | 93.1 Million |
| Depreciation & Amortization | 63.13 Million | 62.05 Million | 53.02 Million | 15.3 Million | 14.5 Million | 20.63 Million |
| Deferred income taxes | - | - | - | - | 4.78 Million | 218 Thousand |
| Stock-based compensation | - | - | - | - | 5.69 Million | 5.83 Million |
| Change in working capital | 26.99 Million | -11.33 Million | -54 Million | -23.22 Million | 43.38 Million | -5.84 Million |
| Other non-cash items | -28.1 Million | -46.06 Million | -16.56 Million | -18.1 Million | 1.75 Million | -2.23 Million |
| Investing Cash Flow | -213.36 Million | 49.59 Million | -77 Million | 20.37 Million | -246.39 Million | -84.47 Million |
| Investments in PPE | -14.84 Million | -14.96 Million | -25.77 Million | -66.83 Million | -202.03 Million | -95.32 Million |
| Acquisitions | 1.14 Million | 56.48 Million | 21.12 Million | - | -527 Thousand | - |
| Investment purchases | -201.79 Million | -44.71 Million | -72.35 Million | 29.7 Million | -86.68 Million | - |
| Sales/Maturities of investments | 2.01 Million | 52.79 Million | 115.89 Million | 56.3 Million | 41.74 Million | 10.84 Million |
| Other Investing Activities | 111 Thousand | -6000.00 | -115.89 Million | 1.2 Million | 1.09 Million | 9.7 Million |
| Financing Cash Flow | -134.53 Million | -299.71 Million | 240.05 Million | -80.53 Million | 4.18 Million | 11.68 Million |
| Debt repayment | -4.06 Million | -904.52 Million | -910 Million | -230 Million | -460.75 Million | -64.51 Million |
| Dividends payments | -133.3 Million | -93.83 Million | -58.55 Million | -79.26 Million | -92.96 Million | -10.32 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 236.74 Million | 86.51 Million |
| Other Financing Activities | 2.83 Million | 698.63 Million | 1.2 Billion | 228.72 Million | 321.16 Million | 86.51 Million |
| Accounts receivables | -4.49 Million | -12.18 Million | -10.33 Million | -6.95 Million | 13.19 Million | -19.08 Million |
| Accounts payables | -3.2 Million | 6.77 Million | -11.32 Million | 4.8 Million | -4.23 Million | 10.36 Million |
| Inventory | 8.61 Million | -13 Million | -37.02 Million | -12.67 Million | 9.36 Million | -7.16 Million |
| Other working capital | 26.08 Million | 7.08 Million | 4.67 Million | -8.39 Million | 25.05 Million | 1.31 Million |
| Cash at beginning of period | 587.01 Million | 658.91 Million | 397.36 Million | 331.04 Million | 368.95 Million | 330.08 Million |
| Cash at end of period | 511.1 Million | 587.01 Million | 658.91 Million | 397.36 Million | 331.04 Million | 368.95 Million |
| Capital Expenditure | -14.84 Million | -14.96 Million | -25.77 Million | -66.83 Million | -202.03 Million | -95.32 Million |
| Effect of forex changes on cash | -33 Thousand | 14 Thousand | -7000.00 | 11 Thousand | -93 Thousand | -41 Thousand |
| Net cash flow / Change in cash | -75.91 Million | -71.9 Million | 261.55 Million | 66.31 Million | -37.9 Million | 38.86 Million |
| Free Cash Flow | 257.16 Million | 163.24 Million | 72.73 Million | 59.63 Million | 2.36 Million | 16.37 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 67.81 Million | 64.95 Million | 209.99 Million | 49.39 Million | 72.42 Million | 46.38 Million |
| Depreciation & Amortization | 15.83 Million | 15.82 Million | 63.13 Million | 15.81 Million | 15.76 Million | 15.84 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -36.93 Million | -536 Thousand | 26.99 Million | 19.71 Million | 16.78 Million | 4.06 Million |
| Other non-cash items | 73.24 Million | -2.29 Million | -28.1 Million | -3.26 Million | -14.23 Million | -11.34 Million |
| Investing Cash Flow | 7.62 Million | -33.79 Million | -213.36 Million | -236.24 Million | 27.63 Million | 29.85 Million |
| Investments in PPE | -6.47 Million | -3.83 Million | -14.84 Million | -2.35 Million | -3.97 Million | -4.38 Million |
| Acquisitions | - | 190 Thousand | 1.14 Million | - | -31.61 Million | 1.23 Million |
| Investment purchases | -249.9 Million | -30.15 Million | -201.79 Million | -233.9 Million | 31.61 Million | 31 Million |
| Sales/Maturities of investments | 264 Million | 49.9 Million | 2.01 Million | - | 3000.00 | 33 Million |
| Other Investing Activities | 13.98 Million | -29.96 Million | 111 Thousand | 10 Thousand | 31.61 Million | -31 Million |
| Financing Cash Flow | -306 Thousand | -310 Thousand | -134.53 Million | -309 Thousand | -133.6 Million | -307 Thousand |
| Debt repayment | -306 Thousand | -310 Thousand | -4.06 Million | -3.97 Million | -588 Thousand | -58 Thousand |
| Dividends payments | - | - | -133.3 Million | - | -133.3 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -306 Thousand | - | 2.83 Million | 3.66 Million | 279.99 Thousand | -249 Thousand |
| Accounts receivables | -43.76 Million | -22.25 Million | -4.49 Million | 35.66 Million | -13.54 Million | -36.91 Million |
| Accounts payables | -5.65 Million | 14.37 Million | -3.2 Million | 5.13 Million | -1.61 Million | -5.28 Million |
| Inventory | 10.2 Million | -5.58 Million | 8.61 Million | 6.57 Million | 1.62 Million | 1.96 Million |
| Other working capital | 2.28 Million | 12.92 Million | 26.08 Million | -27.66 Million | 30.31 Million | 44.29 Million |
| Cash at beginning of period | 554.99 Million | 511.1 Million | 587.01 Million | 666.04 Million | 680.97 Million | 596.77 Million |
| Cash at end of period | 611.38 Million | 554.99 Million | 511.1 Million | 511.1 Million | 666.04 Million | 680.97 Million |
| Capital Expenditure | -6.47 Million | -3.83 Million | -14.84 Million | -2.35 Million | -3.97 Million | -4.38 Million |
| Effect of forex changes on cash | 11 Thousand | 27 Thousand | -33 Thousand | -40 Thousand | 297 Thousand | -293 Thousand |
| Net cash flow / Change in cash | 56.39 Million | 43.89 Million | -75.91 Million | -154.94 Million | -14.93 Million | 84.2 Million |
| Free Cash Flow | 42.58 Million | 74.13 Million | 257.16 Million | 79.29 Million | 86.76 Million | 50.56 Million |
GMPUF
EASTWEST
024720
OTC
3911
000523